Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare, progressive heart disease caused by the buildup of abnormal deposits of a protein called amyloid in the heart muscle. Amyloid is an abnormal protein that is not able to be broken down and eliminated by the body. Over time, these amyloid deposits weaken and stiffen the heart muscle, affecting its ability to pump blood efficiently. https://www.ukwebwire.com/transthyretin-amyloid-cardiomyopathy-treatment-market-growth-and-trnds-analysis-share-size-demand-forecast//